Basic Information
Experimental Physicochemical Property
| Property Name | Property Value | Unit | Raw Value | Raw Unit | Reference |
|---|---|---|---|---|---|
| Melting Point | 250.0 | ℃ | 250 | ℃ | PhysProp |
Pharmacokinetic/ Toxicokinetic Property
| Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Reference |
|---|---|---|---|---|---|---|
| AUC | 44200.0 | ng.h/ml | 44.2 | mg.h/l | intravenous injection, IV; | DRUGBANK | AUC | 47500.0 | ng.h/ml | 47.5 | mg.h/l | IM,intramuscular injection; | DRUGBANK |
| Bioavailability | 1.5 | % | 1-2 | % | PO, oral; | DRUGBANK |
| C Max | 16100.0 | ng/ml | 16.1 | mg/L | intravenous injection, IV; | DRUGBANK | C Max | 12800.0 | ng/ml | 12.8 | mg/L | IM,intramuscular injection; | DRUGBANK |
| Metabolic | 0 | % | 0 | % | human, homo sapiens; | DRUGBANK |
| Clearance | 5.4 | L/h | ~90 | ml/min | Renal clearance; | DRUGBANK |
| Half-life | 5.6 | h | 5.6 | h | elimination half-life; | DRUGBANK |
| Protein Binding | 36.0 | % | 36 | % | plasma proteins; | DRUGBANK |
Maximum Dosage
Not Available
Drug Property Radar Chart
Note: Center: Q1-1.5*IQR, Edge: Q3+1.5*IQR; Q1: Quantile 1, Q3: Quantile 3, IQR: Q3-Q1